Ginkgo biloba extract and long-term cognitive decline: a 20-year follow-up population-based study.
Numerous studies have looked at the potential benefits of various nootropic drugs such as Ginkgo biloba extract (EGb761®; Tanakan®) and piracetam (Nootropyl®) on age-related cognitive decline often leading to inconclusive results due to small sample sizes or insufficient follow-up duration. The pres...
Main Authors: | Hélène Amieva, Céline Meillon, Catherine Helmer, Pascale Barberger-Gateau, Jean François Dartigues |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3543404?pdf=render |
Similar Items
-
PUFAs and risk of cognitive decline or dementia: epidemiological data
by: Barberger-Gateau Pascale
Published: (2007-05-01) -
Ginkgo Biloba
by: Sami J. Natour, MD, et al.
Published: (2020-06-01) -
Mediterranean diet and cognitive decline: what role for omega-3 polyunsaturated fatty acids?
by: Barberger-Gateau Pascale, et al.
Published: (2011-07-01) -
Ginkgo biloba e câncer
by: Fernanda Lasakosvitsch Castanho, et al.
Published: (2007-01-01) -
Ginkgo biloba for the treatment of tinnitus
by: Felipe Kramer, et al.
Published: (2018-10-01)